Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

e25.00353 http://scihub22266oqcxt.onion/e25.00353 41264685!?!41264685       JBJS+Case+Connect 2025 ; 15 (4): ? Nephropedia Template TP {{tp|p=41264685|t=2025. A Novel Approach to the Treatment of Familial Expansile Osteolysis: A Rare Genetic Bone Pathology: A Case Report |pdf=|usr=}}{{41264685}} gab.com Text A Novel Approach to the Treatment of Familial Expansile Osteolysis: A Rare Genetic Bone Pathology: A Case Report JO: JBJS Case Connect http://www.kidney.de/pget.php?&tw=1&pmid=41264685 #FOAvip CASE: Familial expansile osteolysis (FEO) is a rare inherited autosomal dominant condition causing the development of painful lytic bone lesions. We present the case of a 54-year-old man with FEO who was treated with denosumab. The patient's progress was monitored with radiographs, magnetic resonance imaging, bone turnover markers, pain, and functional scores. CONCLUSION: The use of denosumab for FEO displays improvement in radiological appearances of the affected bone, increased quality of life and may prevent the development of further lesions. It is a safe treatment modality for patients with FEO that allows for limb salvage surgery rather than amputation. Twit Text FOAVip A Novel Approach to the Treatment of Familial Expansile Osteolysis: A Rare Genetic Bone Pathology: A Case Report ????JBJS Case Connect http://www.kidney.de/pget.php?&tw=1&pmid=41264685 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=41264685 #FOAvip English Wikipedia <ref>{{Cite pmid|41264685}}</ref> A Novel Approach to the Treatment of Familial Expansile Osteolysis: A Rare Genetic Bone Pathology: A Case Report #MMPMID41264685 Lennon S; Allen P; Johnson L JBJS Case Connect 2025[Oct]; 15 (4): ? PMID41264685show ga CASE: Familial expansile osteolysis (FEO) is a rare inherited autosomal dominant condition causing the development of painful lytic bone lesions. We present the case of a 54-year-old man with FEO who was treated with denosumab. The patient's progress was monitored with radiographs, magnetic resonance imaging, bone turnover markers, pain, and functional scores. CONCLUSION: The use of denosumab for FEO displays improvement in radiological appearances of the affected bone, increased quality of life and may prevent the development of further lesions. It is a safe treatment modality for patients with FEO that allows for limb salvage surgery rather than amputation. |*Bone Density Conservation Agents/therapeutic use[MESH] |*Denosumab/therapeutic use[MESH] |*Osteolysis/drug therapy/diagnostic imaging/genetics[MESH] |Humans[MESH] |Male[MESH]A Novel Approach to the Treatment of Familial Expansile Osteolysis: A (epmc).pdf DeepDyve Pubget Overpricing